Invicta Diagnostic Limited (NSE:INVICTA)
India · Delayed Price · Currency is INR 74.35
+1.35 (1.85%)
At close: Jan 19, 2026
Invicta Diagnostic Revenue
In the fiscal year ending March 31, 2025, Invicta Diagnostic had annual revenue of 301.81M INR with 89.84% growth. Invicta Diagnostic had revenue of 85.40M in the quarter ending September 30, 2025.
Revenue
301.81M
Revenue Growth
+89.84%
P/S Ratio
3.02
Revenue / Employee
2.87M
Employees
105
Market Cap
910.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 301.81M | 142.83M | 89.84% |
| Mar 31, 2024 | 158.98M | 90.55M | 132.33% |
| Mar 31, 2023 | 68.43M | 39.40M | 135.74% |
| Mar 31, 2022 | 29.03M | - | - |
| Mar 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.25T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| HDFC Bank | 2.85T |
| Larsen & Toubro | 2.76T |
| Tata Consultancy Services | 2.61T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |